DNA-magnetic Particle Binding Analysis by Dynamic and Electrophoretic Light Scattering
November 9th, 2017
This protocol describes the synthesis of magnetic particles and evaluation of their DNA-binding properties via dynamic and electrophoretic light scattering. This method focuses on monitoring changes in particle size, their polydispersity and zeta potential of particle surface which play major role in binding of materials such as DNA.
The overall goal of this experiment is to analyze binding of DNA and Magnetic Particles via Dynamic and Electrophoretic Light Scattering.This method can help answer key questions in the Biotechnology field such as, how fast and strong is the binding between nucleic acid and magnetic particles.The main advantage of this technique is the visualization of physical-chemical changes on the particles such as size, polydispersity or zeta potential.The implications of this technique extend towards molecular diagnosis because of increasing demand for fast and sensitive DNA isolation.In this procedure, add 20 millimoles of Ferric Chloride and ten millimoles of Ferrous Chloride in 20 milliliters of Deoxygenated Double Distilled Water.Next, stir the obtained solution vigorously in beaker under Nitrogen gas atmosphere using a mechanical stirrer until a transparent solution is obtained.Then, under rapid mechanical stirring, add 150 milliliters of one molar of aqueous ammonia drop by drop using dropping funnel over an hour.Afterward, transfer the solution into a screwable vessel and heat the solution at 75
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol describes the synthesis of magnetic particles and their evaluation for DNA-binding properties. It focuses on monitoring changes in particle size, polydispersity, and zeta potential, which are crucial for effective DNA binding.
Key Study Components
Area of Science
- Biomaterials
- Nanotechnology
- Molecular Biology
Background
- Magnetic particles have applications in biotechnology.
- Understanding DNA binding is essential for various molecular applications.
- Particle characteristics influence binding efficiency.
- Dynamic and electrophoretic light scattering are key techniques for evaluation.
Purpose of Study
- To synthesize magnetic particles.
- To evaluate their DNA-binding properties.
- To assess the impact of particle characteristics on binding efficiency.
Methods Used
- Synthesis of magnetic particles.
- Dynamic light scattering for size measurement.
- Electrophoretic light scattering for zeta potential analysis.
- Evaluation of polydispersity in particle samples.
Main Results
- Successful synthesis of magnetic particles.
- Characterization of particle size and zeta potential.
- Correlation between particle properties and DNA binding efficiency.
- Insights into optimizing particle design for biological applications.
Conclusions
- The synthesized magnetic particles show promising DNA-binding properties.
- Particle size and surface charge are critical for binding efficiency.
- This method provides a framework for future studies in biomolecular interactions.
Frequently Asked Questions
Executive Industry Relevance
This method enables biopharma R&D teams to evaluate DNA-magnetic particle binding through measurable physicochemical changes, supporting target validation and assay development for nucleic acid isolation workflows. By quantifying shifts in particle size, polydispersity, and zeta potential, it provides predictive confidence in particle performance under defined binding and elution conditions. This facilitates mechanistic de-risking in early discovery by linking particle design to functional DNA capture efficiency.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by correlating particle surface modifications with DNA binding efficiency under controlled pH and ionic strength conditions.
- Operational Value: Enables rapid screening of nanoparticle and microparticle formulations for nucleic acid capture capability using DLS and ELS readouts.
Screening & Assay Development
- Scientific Value: Provides quantitative, reproducible measurements of particle aggregation and surface charge shifts as proxies for DNA binding and elution efficiency.
- Operational Value: Standardizes particle evaluation across chemical variants (branched PEI, TEOS, APTES) to support assay readiness and platform scalability.
Translational & Preclinical Research
- Scientific Value: Supports translational biomarker alignment by establishing particle performance benchmarks applicable to disease-relevant nucleic acid isolation systems.
- Operational Value: Enables risk-adjusted advancement decisions by linking particle physicochemistry to functional DNA yield via qPCR validation.
Pipeline & Workflow Integration
This technique fits within the early discovery continuum, informing lead identification by providing biophysical feedback on particle-nucleic acid interactions before functional validation in downstream applications.
- Discovery Biology: Supports hypothesis testing of particle-DNA interactions through real-time monitoring of size and zeta potential changes during binding and elution cycles.
- Screening: Delivers assay-ready, standardized outputs (hydrodynamic size, PDI, zeta potential) that enable comparison across particle formulations under consistent buffer conditions.
- Analytics: Generates correlative datasets linking DLS/ELS metrics to qPCR-derived DNA copy number, enabling data-driven particle selection.
- Translational Research: Connects particle design to preclinical continuity by validating isolation efficiency in low-pH, high-salt environments mimicking sample preparation conditions.
- Enterprise Reuse: Establishes a reusable physicochemical screening platform for evaluating magnetic particles across diverse biomolecular targets beyond DNA.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in nucleic acid isolation by directly measuring binding-induced changes in particle dispersion and surface charge.
- Operational Value: Enhances reproducibility and standardization of particle evaluation through DLS and ELS, minimizing batch-to-batch variability in magnetic reagent performance.
- Strategic Value: Improves go/no-go decisions in reagent development by providing early, quantitative predictors of DNA binding and elution efficiency.
- Portfolio Impact: Enables risk-adjusted prioritization of particle candidates based on binding stability and release profiles under defined workflow conditions.
Implementation Considerations
- Requires expertise in colloid science and light scattering instrumentation for accurate DLS and ELS data acquisition and interpretation.
- Dependent on access to calibrated dynamic and electrophoretic light scattering analyzers capable of measuring zeta potential and size distribution in complex buffers.
- Necessitates standardization of particle washing and resuspension protocols to ensure consistent magnetic separation and minimize non-specific aggregation artifacts.
- Must account for buffer-specific effects (pH, ionic strength) on particle stability and DNA binding when adapting the method to alternative nucleic acid targets or sample types.
- Limited to detecting bulk population changes; cannot resolve heterogeneous binding subpopulations without complementary single-particle techniques.
Biopharma FAQs
Chapters in this video
0:05
Title
0:49
Synthesis of Magnetic Nanoparticles (MNPs)
3:07
Chemical Modification of Magnetic Nanoparticles
5:53
Magnetic Particle Size Analysis Using DLS
6:46
Testing Efficiency of DNA Isolation Using Quantitative PCR
7:58
Magnetic Particle Zeta Potential Analysis Using DLS
8:37
Results: Zeta Potential of Representative Magnetic Particles Over Time in Presence and Absence of DNA
9:57
Conclusion
